Table 5.
Effects of POC or its components on tumor size (greater than median).
| b (95% CI) | p-value | AIC a | |
|---|---|---|---|
| Non-adjusted | |||
| POC | 0.991 (0.983-0.998) | 0.017 | 641.993 |
| Sex | 0.950 (0.608-1.484) | 0.820 | 647.799 |
| Age at exposure, years | 1.039 (1.003-1.076) | 0.032 | 643.192 |
| Latency period, years | 0.965 (0.932-0.999) | 0.043 | 643.708 |
| Age at operation, years | 1.001 (0.978-1.025) | 0.930 | 647.842 |
| Thyroid dose, mGy (log) | 0.896 (0.762-1.055) | 0.188 | 646.086 |
| Model 1 | 644.147 | ||
| Sex | 0.917 (0.581-1.445) | 0.708 | |
| Age at exposure, years | 1.035 (0.993-1.078) | 0.105 | |
| Latency period, years | 0.961 (0.927-0.995) | 0.027 | |
| Thyroid dose, mGy (log) | 0.948 (0.781-1.151) | 0.591 | |
| Model 2 | 649.687 | ||
| Sex | 0.969 (0.618-1.520) | 0.893 | |
| Age at operation, years | 0.991 (0.965-1.019) | 0.535 | |
| Thyroid dose, mGy (log) | 0.872 (0.724-1.051) | 0.152 | |
Akaike information criterion.
Numbers in bold indicate statistical significance.